Publications 2014

Ewe A, Schaper A, Barnert S, Schubert R, Temme A, Bakowsky U,Aigner A
Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery
Acta Biomater. 2014 Feb 28. pii: S1742-7061(14)00089-0. doi: 10.1016/j.actbio.2014.02.037. [Epub ahead of print]

Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.
Brain.2014 Feb 27. [Epub ahead of print]

Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker GA, Patt M, Thomae E, Seese A, Meyer PM, Bergh FT, Sabri O.
Altered serotonin transporter availability in patients with multiple sclerosis
Eur J Nucl Med Mol Imaging.2014 Feb 22. [Epub ahead of print]

Xu H, Rösler TW, Carlsson T, de Andrade A, Fiala O, Hollerhage M, Oertel WH, Goedert M, Aigner A, Höglinger GU.
Tau silencing by siRNA in the P301S mouse model of tauopathy.
Curr Gene Ther. 2014;14(5):343-51.

Ertych N, Stolz A, Stenzinger A, Weichert W, Kaulfuß S, Burfeind P, Aigner A, Wordeman L, Bastians H.
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.
Nat Cell Biol. 2014 Aug;16(8):779-91. doi: 10.1038/ncb2994.

Frömberg A, Rabe M, Aigner A.
Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Int J Cancer. 2014 Dec 1;135(11):2537-46. doi: 10.1002/ijc.28895.

Dakwar GR, Zagato E, Delanghe J, Hobel S, Aigner A, Denys H, Braeckmans K, Ceelen W, De Smedt SC, Remaut K.
Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapy.
Acta Biomater. 2014 Jul;10(7):2965-75. doi: 10.1016/j.actbio.2014.03.012.

Stoehr M, Mozet C, Boehm A, Aigner A, Dietz A, Wichmann G.
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Cancer Chemother Pharmacol. 2014 Apr;73(4):827-37. doi: 10.1007/s00280-014-2412-1.

Höbel S, Vornicescu D, Bauer M, Fischer D, Keusgen M, Aigner A.
A novel method for the assessment of targeted PEI-based nanoparticle binding based on a static surface plasmon resonance system.
Anal Chem. 2014 Jul 15;86(14):6827-35. doi: 10.1021/ac402001q.

Kehagia AA, Housden CR, Regenthal R, Barker RA, Müller U, Rowe J, Sahakian BJ, Robbins TW.
Targeting impulsivity in Parkinson's disease using atomoxetine.
Brain. 2014 Jul;137(Pt 7):1986-97. doi: 10.1093/brain/awu117.

Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.
Brain. 2014 Apr;137(Pt 4):1145-55. doi: 10.1093/brain/awu032

Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker GA, Patt M, Thomae E, Seese A, Meyer PM, Bergh FT, Sabri O.
Altered serotonin transporter availability in patients with multiple sclerosis.
Med Mol Imaging. 2014 Aug;41(8):1640-1.